Antimalarial effect in vitro and lack of modulating effect of desipramine and imipramine

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 6, 1997, Pages 697-700

  Menezes, C M S ^a,b   Kirchgatter, K ^c   Di Santi, S M F ^c   Savalli, C ^b   Monteiro, F G ^b   Paula, G A ^b   Ferreira, E I ^b  

^a PAULISTA UNIVERSITY   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SUPERINTENDÊNCIA DE CONTROLE DE ENDEMIAS   (Brazil)

Author keywords

Chemotherapy; Chloroquine; Desipramine; Drug resistance; Imipramine; Malaria; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DESIPRAMINE; IMIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; NONHUMAN; PARASITE CULTIVATION; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031447130     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90529-0     Document Type: Article

References (33)

1. Barnes, D. A., Foote, S. J., Galatis, D., Kemp, D. J. & Cowman, A. F. (1992). Selection for high-level chloroquine resistance in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO Journal, 11, 3067-3075.
2. Basco, L. K. & Le Bras, J. (1990a). Reversal of chloroquine resistance with desipramine in isolates of Plasmodium falciparum from Central and West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 479-481.
3. Basco, L. K. & Le Bras, J. (1990b). Desipramine or cyproheptadine for reversing chloroquine resistance? Lancet, 335, 422.
4. Biedler, J. L. & Riehm, H. (1970). Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic and cytogenetic studies. Cancer Research, 30, 1174-1184.
5. Bitonti, A. J. & McCann, P. P. (1989). Desipramine and cyproheptadine for reversal of chloroquine resistance in Plasmodium falciparum. Lancet, 334, 1282-1283.
6. Bitonti, A. J., Sjoerdsma, A., McCann, P. P., Kyle, D. E., Oduola, A. M. J., Rossan, R. N., Milhous, W. K. & Davidson, D. E., jr (1988). Reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum by desipramine. Science, 242, 1301-1303.
7. Bitonti, M. K., Bray, P. G., Howells, R. E. & Ward, S. A. (1993). The potential of desipramine to reverse chloroquine resistance of Plasmodium falciparum is reduced by its binding to plasma protein. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 303.
8. Breslow, N. E. & Day, N. E. (1980). Statistical Methods in Cancer Research 1. The Analysis of Case Control Studies. Lyon: International Agency for Research on Cancer.
9. Bruce-Chwatt, L. J. (editor) (1982). Chemotherapy of Malaria, 2nd edition. Geneva: World Health Organization, pp. 211-223.
10. Clarke, E. C. (1986). Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids and Post-mortem Material, 2nd edition. London: Pharmaceutical Press, pp. 516-517 & 679-680.
11. Collet, D. (1991). Modeling Binary Data. London: Chapman & Hall.
12. Cowman, A. F. (1991). The P-glycoprotein homologues of Plasmodium falciparum. Are they involved in chloroquine resistance? Parasitology Today, 7, 70-75.
13. Foote, S. J., Kyle, D. E., Martin, R. K., Oduola, A. M. J., Forsyth, K., Kemp, D. J. & Cowman, A. F. (1990). Several alleles of multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature, 345, 255-258.
14. Ford, J. M. & Hait, W. N. (1990). Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacological Reviews, 42, 155-199.
15. Ginsburg, H. (1991). Enhancement of the antimalarial effect of chloroquine on drug-resistant parasite strains - a critical examination of the reversal of multidrug resistance. Experimental Parasitology, 73, 227-232.
16. Hardmam, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W. & Gilman, G. (1996). Goodman & Gilman's - The Pharmacological Basis of Therapeutics, 9th edition. New York: Pergamon Press, pp. 1733 & 1749.
17. Honegger, U. E., Roscher, A. A. & Wiesmann, U. N. (1983). Evidence for lysosomotropic action of desipramine in cultured human fibroblasts. Journal of Pharmacology and Experimental Therapeutics, 225, 436-441.
18. Kanno, K. & Sasaki, Y. (1982). Interaction of psychotropic drugs with phospholipids. Biochemical Pharmacology, 31, 2977-2981.
19. Krogstad, D. J., Gluzman, I. Y., Kyle, D. E., Oduola, A. M. J., Martin, S. K., Milhous, W. K. & Schlesinger, P. H. (1987). Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science, 238, 1283-1285.
20. Kyle, D. E., Oduola, A. M. J., Martin, S. K. & Milhous, W. K. (1990). Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 474-478.
21. Le Bras, J. & Deloron, P. (1983). In vitro study of drug sensitivity Plasmodium falciparum: evaluation of a new semi-micro test. American Journal of Tropical Medicine and Hygiene, 32, 447-451.
22. Martin, S. K., Oduola, A. M. J. & Milhous, W. K. (1987). Reversal of chloroquine in Plasmodium falciparum by verapamil. Science, 235, 899-901.
23. Moore, D. V. & Lanier, J. E. (1961). Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. American Journal of Tropical Medicine and Hy-giene, 10, 5-9.
24. Olliaro, P. L. & Trigg, P. I. (1995). Status of antimalarial drugs under development. Bulletin of the World Health Organization, 73, 565-571.
25. Peters, W., Ekong, R., Robinson, B. L., Warhurst, D. C. & Xin-Qing, P. (1990). The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents. Annals of Tropical Medicine and Parasitology, 84, 541-551.
26. Reynolds, C. H. & Claxton, P. T. J. (1982). Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin. Biochemical Pharmacology, 31, 419-421.
27. Rieckmann, K. H., Sax, L. J., Campbell, G. H. & Mrema, J. E. (1978). Drug sensitivity of Plasmodium falciparum. An invitro microtechnique. Lancet, i, 22-23.
28. Riordan, J. R. & Ling, V. (1985). Genetic and biochemical characterization of multidrug resistance. Pharmacology and Therapeutics, 28, 51-75.
29. Rubio, J. P. & Cowman, A. F. (1994). Plasmodium falciparum: the pfmdr2 protein is not overexpressed in chloroquineresistant isolates of the malaria parasite. Experimental Parasitology, 79, 137-147.
30. Trager, W. & Jensen, B. B. (1976). Human malaria parasites in continuous culture. Science, 193, 673-675.
31. Warsame, M., Wernsdorfer, W. H. & Björkman, A. (1992). Lack of effect of desipramine on the response to chloroquine of patients with chloroquine-resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 235-236.
32. Wellems, T. E., Panton, L. J., Gluzman, I. Y., Rosario, V. E., Gwadz, R. W., Walker-Jonah, A. & Krogstad, D. J. (1990). Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature, 345, 253-255.
33. Wilson, C. M., Volkman, S. K., Thaithong, S., Martin, R. K., Kyle, D. E., Milhous, W. K. & Wirth, D. F. (1993). Amplification of pfmdrl associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Molecular and Biochemical Parasitology, 57, 151-160.